Celsion director Andreas Voss retires from board effective Dec 31, 2021

Imunon, Inc.

Dr. Andreas Voss, a Class III director, will retire from the Board effective December 31, 2021.
Voss served on the Science & Technology Committee and as a strategic advisor to the CEO during 2020-2021.
He will continue as Managing Director of Celsion GmbH, a wholly owned subsidiary, focusing on strategy and management.
Retirement is due to time demands of the subsidiary role, not disagreement with management or the Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andreas Voss

Director

IMNN · Imunon, Inc.

Effective: 2021-12-31
Filed: December 30, 2021, 6:59 PM ET

Dr. Andreas Voss, a Class III member of the Board of Directors (the “Board”) will retire from the Company’s Board effective December 31, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andreas Voss retired as Director at Imunon, Inc..

Action: retired
Role: Director

Exact text from the filing

Dr. Andreas Voss, a Class III member of the Board of Directors (the “Board”) will retire from the Company’s Board effective December 31, 2021.

View on SEC.gov

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-032854

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.